titanpharm.comTitan Pharmaceuticals, Inc. (TTNP)
titanpharm.com Profile
titanpharm.com is a domain
that was created on 1997-02-14,making it 28 years ago.
It has several subdomains, such as ir.titanpharm.com , among others.
Description：Titan Pharmaceuticals, Inc. -...
Discover titanpharm.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
titanpharm.com Information
| HomePage size: 25.215 KB |
| Page Load Time: 0.639939 Seconds |
| Website IP Address: 54.208.101.55 |
titanpharm.com Similar Website
| Investor Relations :: CNS Pharmaceuticals, Inc. (CNSP) |
| Mirum Pharmaceuticals, Inc. - Investor Relations |
| Amneal Pharmaceuticals, Inc. - Investor Relations |
| Titan Protection Security | Home | Titan Protection |
| Investors :: Conatus Pharmaceuticals Inc. (CNAT) |
| Investor Relations - Spectrum Pharmaceuticals, Inc. |
| Ironwood Pharmaceuticals, Inc. - Company Overview |
| Investor Relations | Regeneron Pharmaceuticals Inc. |
| Investors & Media | Ionis Pharmaceuticals, Inc. |
| Press Releases | Alexion Pharmaceuticals, Inc. |
| Press Releases | Alexion Pharmaceuticals, Inc. |
| Investor Relations :: Titan Pharmaceuticals, Inc. (TTNP) |
| Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
| Titan International, Inc. - |
titanpharm.com PopUrls
| Titan Pharmaceuticals, Inc. (TTNP) https://www.titanpharm.com/ |
| Investor Relations :: Titan Pharmaceuticals, Inc. (TTNP) https://ir.titanpharm.com/ |
| Profile :: Titan Pharmaceuticals, Inc. (TTNP) https://ir.titanpharm.com/profile |
| ProNeura https://www.titanpharm.com/technology |
| Charts https://ir.titanpharm.com/charts |
| Financials https://ir.titanpharm.com/financials |
| Quote :: Titan Pharmaceuticals, Inc. (TTNP) https://ir.titanpharm.com/quote |
| FAQ :: Titan Pharmaceuticals, Inc. (TTNP) https://ir.titanpharm.com/faq |
| Disclaimer https://www.titanpharm.com/disclaimer |
| Who We Are :: Titan Pharmaceuticals, Inc. (TTNP) https://www.titanpharm.com/about/who-we-are |
| Company Information :: Titan Pharmaceuticals, Inc. (TTNP) https://ir.titanpharm.com/company-information |
| About Titan Pharmaceuticals :: Titan Pharmaceuticals, Inc. (TTNP) https://www.titanpharm.com/about/overview |
| Titan Announces Positive Results from the First Studies of TP-2021 ... https://www.titanpharm.com/news/press-releases/detail/257/titan-announces-positive-results-from-the-first-studies-of |
| Titan Pharmaceuticals Announces Reverse Stock Split and Ratio https://ir.titanpharm.com/press-releases/detail/271/titan-pharmaceuticals-announces-reverse-stock-split-and |
| Press Releases :: Titan Pharmaceuticals, Inc. (TTNP) https://www.titanpharm.com/news/press-releases |
titanpharm.com DNS
| A titanpharm.com. 3600 IN A 54.208.101.55 |
| MX titanpharm.com. 3600 IN MX 0 titanpharm-com.mail.protection.outlook.com. |
| NS titanpharm.com. 3600 IN NS ns07.domaincontrol.com. |
| TXT titanpharm.com. 3600 IN TXT v=spf1 include:spf.ess.barracudanetworks.com include:spf.protection.outlook.com include:_spf.psm.knowbe4.com ~all |
| SOA titanpharm.com. 3600 IN SOA ns07.domaincontrol.com. dns.jomax.net. 2021111705 28800 7200 604800 3600 |
titanpharm.com Httpheader
| Date: Tue, 14 May 2024 15:52:57 GMT |
| Server: Apache |
| Vary: Accept-Encoding |
| Transfer-Encoding: chunked |
| Content-Type: text/html; charset=UTF-8 |
titanpharm.com Meta Info
| charset="utf-8"/ |
| content="Titan Pharmaceuticals, Inc. - Home" name="description"/ |
| content="Titan Pharmaceuticals, Inc." property="og:site_name"/ |
| content="Titan Pharmaceuticals, Inc." property="og:title"/ |
| content="website" property="og:type"/ |
| content="https://d1io3yog0oux5.cloudfront.net/_6e474d13f738b7e72c50e873d17b8cbf/titanpharm/logo.png" property="og:image"/ |
| content="https://www.titanpharm.com" property="og:url"/ |
| content="Titan Pharmaceuticals, Inc. - Home" property="og:description"/ |
| content="initial-scale=1.0, width=device-width" name="viewport"/ |
| content="#ffffff" name="msapplication-TileColor"/ |
| content="https://d1io3yog0oux5.cloudfront.net/_6e474d13f738b7e72c50e873d17b8cbf/titanpharm/files/images/mstile-144x144.png" name="msapplication-TileImage"/ |
| content="#ffffff" name="theme-color"/ |
titanpharm.com Ip Information
| Ip Country: United States |
| City Name: Ashburn |
| Latitude: 39.0469 |
| Longitude: -77.4903 |
Leaflet © OpenStreetMap contributors |
titanpharm.com Html To Plain Text
Navigate Titan Pharmaceuticals, Inc. Home About Overview Who We Are IP Portfolio Management Team Board of Directors Careers Technology Pipeline Kappa Opioid Receptor Agonist Nalmefene Implant News Overview Press Releases Events Presentations In the News Publications Posters Media Resources Investors Overview News / Events Company Information Stock Data SEC Filings Corporate Governance Contact Search Innovations in Medicine ProNeura ® , Titan’s innovative drug delivery platform, is advancing the treatment of select chronic diseases by delivering low-dose, non-fluctuating medication levels for up to one year following a single subdermal insertion procedure Learn more about innovations in medicine Product Pipeline Kappa Opioid Receptor Agonist (TP-2021) Implant for the treatment of moderate-to-severe chronic pruritus More About Kappa Opioid Receptor Agonist (TP-2021) Implant Product Pipeline Nalmefene Implant for the prevention of relapse in OUD patients following detoxification from opioids More About Nalmefene Implant About Titan Pharmaceuticals Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes. More About Titan Pharmaceuticals ProNeura ® Read an article by Fortune and watch Chief Scientific Officer Dr. Kate Beebe-DeVarney explain the advantages of the ProNeura long-term continuous drug delivery platform. Visit FortuneWatch the Mechanism of Action video for the ProNeura technology platform and learn how continuous drug release maintains stable blood levels of medication to help treat chronic diseases. Watch MOA Video Information for Investors Titan Pharmaceuticals, Inc. Nasdaq: TTNP Volume Day Low/High 52-Week Low/High Average Volume May 13, 2024 Over 115 million pills containing illicit fentanyl seized by law enforcement in 2023 Over 115 million pills containing illicit fentanyl seized by law enforcement in 2023: Read Article May 9, 2024 AI Tool Using Single-Cell Data Has Promise for Optimally Matching Cancer Drugs to Patients AI Tool Using Single-Cell Data Has Promise for Optimally Matching Cancer Drugs to Patients: Read Article May 8, 2024 More than 321,000 U.S. children lost a parent to drug overdose from 2011 to 2021 More than 321,000 U.S. children lost a parent to drug overdose from 2011 to 2021: Read Article View Investor Relations Download Our Investor Presentation View SEC Filings © 2024 Titan Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy Titan FCOI Policy Disclaimer...
titanpharm.com Whois
Domain Name: TITANPHARM.COM Registry Domain ID: 146920_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-09-11T20:50:57Z Creation Date: 1997-02-14T05:00:00Z Registry Expiry Date: 2027-02-15T05:00:00Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS07.DOMAINCONTROL.COM Name Server: NS08.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:39:20Z <<<